GSK3B and dementia: The serine-threonine protein kinase B (AKT1/2) and GSK3-β are involved in the brain insulin/insulin-like growth-factor-1 (IGF-1) signaling whose dysregulation correlates with the severity of dementia symptoms in sAD [45].